Valeant Pharmaceuticals International, Inc. (NYSE: VRX) has agreed to acquire OraPharma, a specialty oral health company that develops and commercializes ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE